Gray matter atrophy in multiple sclerosis: a longitudinal study (Q34801849)

4 August 2017

Gray matter atrophy in multiple sclerosis: a longitudinal study (English)

1 reference

4 August 2017

0 references

Elizabeth Fisher

1

1 reference

4 August 2017

Jar-Chi Lee

series ordinal

2

1 reference

4 August 2017

Kunio Nakamura

series ordinal

3

1 reference

4 August 2017

Richard A Rudick

series ordinal

4

1 reference

4 August 2017

1 September 2008

1 reference

4 August 2017

1 reference

4 August 2017

64

1 reference

4 August 2017

255-265

1 reference

4 August 2017

3

1 reference

Gray matter involvement in multiple sclerosis

4 August 2017

1 reference

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

21 January 2018

1 reference

Cortical lesions and brain atrophy in MS.

21 January 2018

1 reference

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

21 January 2018

1 reference

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

Review of MR image segmentation techniques using pattern recognition

21 January 2018

1 reference

The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology.

21 January 2018

1 reference

Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data

21 January 2018

1 reference

21 January 2018

1 reference

Breaking down barriers: helpful breakthrough statistical methods you need to understand better

21 January 2018

1 reference

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

21 January 2018

1 reference

The measurement and clinical relevance of brain atrophy in multiple sclerosis

21 January 2018

1 reference

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

21 January 2018

1 reference

Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype.

21 January 2018

1 reference

Relating neocortical pathology to disability progression in multiple sclerosis using MRI

21 January 2018

1 reference

Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study

21 January 2018

1 reference

Evidence for progressive gray matter loss in patients with relapsing-remitting MS.

21 January 2018

1 reference

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

21 January 2018

1 reference

Imaging correlates of axonal swelling in chronic multiple sclerosis brains.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.21436

1 reference

4 August 2017

1 reference